Abstrakt
Data on cardiovascular risk associated with different types of antidiabetic treatments are sparse and conflicting. We examined the risk of hospitalisation with myocardial infarction (MI) among patients treated with sulfonylureas, metformin, insulin, any combination and no antidiabetic pharmacotherapy.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Pharmacoepidemiology and Drug Safety |
Vol/bind | 20 |
Udgave nummer | 4 |
Sider (fra-til) | 331-337 |
Antal sider | 7 |
ISSN | 1053-8569 |
DOI | |
Status | Udgivet - 1 apr. 2011 |